Moscow: Russian scientists have made a big announcement regarding the cancer vaccine and said that the vaccine made by them is now ready for use. Russia's Federal Medical and Biological Agency (FMBA) have announced that the Russian Enteromics cancer vaccine is now ready for clinical use. Russian media outlet Sputin quoted FMBA chief Veronika Skvortsova as saying that the mRNA-based vaccine has succeeded in preclinical trials. The safety and high efficacy of the vaccine have been demonstrated in the last three years.

The Russian vaccine reduces the size of tumors and slows their growth. Skortsovaar said that the vaccine has shown remarkable results in shrinking tumors and slowing their growth by 60 to 80%. It has also been found safe for repeated use. This means that the vaccine is ready for use. He also said that the vaccine will be customized for every patient according to their individual RNA.

Skvortsova told Russian media that the research lasted for several years, with the last three years devoted to mandatory preclinical studies. "The vaccine is now ready for use. We are waiting for official approval," she said. Studies have indicated an increase in survival rates due to the vaccine. FMBA applied to the Ministry of Health to obtain approval for the vaccine this summer.
According to the FMBA head, the first version of the vaccine will be used to treat colorectal cancer, while promising progress has been made in developing vaccines for specific types of glioblastoma (a brain cancer) and melanoma (skin cancer). These are currently in an advanced stage of development.

PC:NBT